Next Issue
Volume 14, October
Previous Issue
Volume 14, June
 
 

Infect. Dis. Rep., Volume 14, Issue 4 (August 2022) – 15 articles

Cover Story (view full-size image): Outbreaks of low pathogenic avian influenza (LPAI) subtype H9 are frequently reported in Nepal. To better understand the risk factors associated with such outbreaks we carried out a case–control study in Chitwan, Nawalpur, and Makwanpur districts, the major poultry hubs in Nepal. A total of 51 case (LPAI subtype H9 positive) and 51 control (LPAI negative) farms were visited, and farmers were surveyed using a semi-structured questionnaire. While distance from the main road (<0.5 km), closeness (<1 km) to the infected farms, and wild birds coming around the farms were identified as the risk factors, the use of a separate apron or cloth inside the farm was observed to reduce the risk of LPAI subtype H9 outbreaks. This study highlights the importance of the right site selection to establish poultry farms and the need to maintain good biosecurity measures outside and within the farms. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Section
Select all
Export citation of selected articles as:
14 pages, 1061 KiB  
Review
Oral Fosfomycin Formulation in Bacterial Prostatitis: New Role for an Old Molecule-Brief Literature Review and Clinical Considerations
by Andrea Marino, Stefano Stracquadanio, Carlo Maria Bellanca, Egle Augello, Manuela Ceccarelli, Giuseppina Cantarella, Renato Bernardini, Giuseppe Nunnari and Bruno Cacopardo
Infect. Dis. Rep. 2022, 14(4), 621-634; https://doi.org/10.3390/idr14040067 - 18 Aug 2022
Cited by 13 | Viewed by 5001
Abstract
Bacterial prostatitis infections are described as infections that are difficult-to-treat, due to prostate anatomic characteristics along with clinical difficulty in terms of diagnosis and management. Furthermore, the emergence of multidrug resistant (MDR) bacteria, such as extended-spectrum beta-lactamase (ESBL) producer Escherichia coli, also representing [...] Read more.
Bacterial prostatitis infections are described as infections that are difficult-to-treat, due to prostate anatomic characteristics along with clinical difficulty in terms of diagnosis and management. Furthermore, the emergence of multidrug resistant (MDR) bacteria, such as extended-spectrum beta-lactamase (ESBL) producer Escherichia coli, also representing the main causative pathogen in prostatitis, poses major problems in terms of antibiotic management and favorable clinical outcome. Oral fosfomycin, an antibiotic commonly used for the treatment of uncomplicated urinary tract infections (UTIs), has been recently evaluated for the treatment of bacterial prostatitis due to its favorable pharmacokinetic profile, its activity against MDR gram-positive and gram-negative bacteria, safety profile, and multiple synergic effect with other antibiotics as well as the low resistance rate. This review addresses fosfomycin pharmacokinetics and pharmacodynamics and discusses the latest clinical evidence on its clinical use to treat acute and chronic bacterial prostatitis in hospitalized patients and in outpatients. As described in several reports, oral fosfomycin may represent a valid therapeutic option to treat susceptible germs commonly causing prostatitis, such as E. coli and other Enterobacterales as well as Enterococcus faecium, even as a first-line regimen in particular clinical settings (patients with previous treatment failure, with allergies or outpatients). Stronger data from further studies, including randomized controlled trials, would be helpful to establish the proper dosage and specific indications. Full article
(This article belongs to the Special Issue Feature Papers in Infectious Diseases)
Show Figures

Figure 1

12 pages, 303 KiB  
Article
An Investigation of Risk Factors Associated with Tuberculosis Transmission in South Africa Using Logistic Regression Model
by Tshepo Frans Maja and Daniel Maposa
Infect. Dis. Rep. 2022, 14(4), 609-620; https://doi.org/10.3390/idr14040066 - 18 Aug 2022
Cited by 2 | Viewed by 2540
Abstract
Background: South Africa has a high burden of tuberculosis (TB) disease and is currently not meeting the national and international reduction outcome targets. The TB prevalence rate of South Africa in 2015 was estimated at approximately 690 per 100,000 population per year, with [...] Read more.
Background: South Africa has a high burden of tuberculosis (TB) disease and is currently not meeting the national and international reduction outcome targets. The TB prevalence rate of South Africa in 2015 was estimated at approximately 690 per 100,000 population per year, with an incidence rate of about 834 per 100,000 population. This study examines risk factors associated with development of TB in South Africa. Materials and Methods: This study utilised readily available open access secondary data of 2019 South African Health and Demographic Survey from Statistics South Africa (StatsSA) website, which was collected from self-reported information relating to TB in the household questionnaire. The factors analysed were of demographic, socio-economic and health nature. Bivariate and binary logistics analyses were carried out from which appropriate inferences were drawn on the association of TB with demographic, socio-economic and health factors. Results: In multivariate analysis the study revealed that age, personal weight, smoke, alcohol, asthma, province of residence, race and usually coughing were significantly associated with an increased risk of having TB. Conclusions and Recommendations: The results strongly suggest that young and older people coming from black and coloured ethic groups, who are asthmatic and cough frequently, and/or smoking and consuming alcohol are at high risk of developing TB. In addition, those who are overweight appear to have an increased risk of TB transmission, with the Western Cape, Eastern Cape, Northern Cape, Free State, North West and Gauteng being the hardest hit provinces. Hence, the study recommends that these factors must be taken into account in the planning and development of TB policies in order to work successfully towards the achievement of sustainable development goal of reducing TB by 80% before 2030. Full article
9 pages, 1412 KiB  
Case Report
Fulminant Influenza A Myocarditis Complicated by Transient Ventricular Wall Thickening and Cardiac Tamponade
by Milan Radovanovic, Igor Dumic, Charles W. Nordstrom and Richard D. Hanna
Infect. Dis. Rep. 2022, 14(4), 600-608; https://doi.org/10.3390/idr14040065 - 15 Aug 2022
Cited by 1 | Viewed by 2120
Abstract
Myocarditis is an infrequent complication of influenza infection that is most often diagnosed clinically in the setting of confirmed influenza infection and elevated cardiac enzymes. Pericarditis can also occur in cases of influenza myocarditis and may require pericardiocentesis for tamponade. Patients with fulminant [...] Read more.
Myocarditis is an infrequent complication of influenza infection that is most often diagnosed clinically in the setting of confirmed influenza infection and elevated cardiac enzymes. Pericarditis can also occur in cases of influenza myocarditis and may require pericardiocentesis for tamponade. Patients with fulminant myocarditis have cardiogenic shock; however, echocardiographic findings may be subtle, showing a preserved ejection fraction and diffuse left ventricular wall thickening (compared to baseline) due to inflammatory edema. Recognizing these echocardiographic findings in the appropriate clinical setting facilitates the early recognition of fulminant myocarditis. Therefore, we report a case of fulminant influenza A myocarditis in healthy 37-year-old women complicated by transient left ventricular wall thickening and tamponade, highlighting the importance of early diagnosis and supportive management for a successful outcome. Full article
Show Figures

Figure 1

3 pages, 200 KiB  
Editorial
The Monkeypox Pandemic as a Worldwide Emergence: Much Ado?
by Massimo Ciccozzi and Nicola Petrosillo
Infect. Dis. Rep. 2022, 14(4), 597-599; https://doi.org/10.3390/idr14040064 - 10 Aug 2022
Cited by 9 | Viewed by 2572
Abstract
The dramatic emergence of SARS-CoV-2 infection worldwide opened the Pandora’s box of fears and frights for new emerging infections [...] Full article
(This article belongs to the Section Viral Infections)
10 pages, 936 KiB  
Article
COVID-19 Disease and Vaccination: Knowledge, Fears, Perceptions and Feelings of Regret for Not Having Been Vaccinated among Hospitalized Greek Patients Suffering SARS-CoV-2 Infection
by Petros Ioannou, Sotiris Tzalis, Eirini Pasparaki, Despoina Spentzouri, Myrto Konidaki, Ioanna Papakitsou, Nikolaos Spernovasilis, Nikolaos Papanikolaou, George Samonis and Diamantis P. Kofteridis
Infect. Dis. Rep. 2022, 14(4), 587-596; https://doi.org/10.3390/idr14040063 - 8 Aug 2022
Cited by 1 | Viewed by 2128
Abstract
Background: The development of vaccines against COVID-19 has greatly altered the natural course of this infection, reducing the disease’s severity and patients’ hospitalization. However, hesitancy against vaccination remains an obstacle in the attempt to achieve appropriate herd immunity that could reduce the spread [...] Read more.
Background: The development of vaccines against COVID-19 has greatly altered the natural course of this infection, reducing the disease’s severity and patients’ hospitalization. However, hesitancy against vaccination remains an obstacle in the attempt to achieve appropriate herd immunity that could reduce the spread of SARS-CoV-2. The aim of this study was to investigate the perceptions and attitudes of COVID-19 patients hospitalized during the fourth pandemic wave in two Greek hospitals and assess whether their experience had changed their intentions regarding vaccination against COVID-19. Methods: This is a cross-sectional, questionnaire-based survey, conducted from 31 August 2021 to 18 February 2022 in the COVID-19 departments of two tertiary care hospitals. The questionnaire included questions regarding the patients’ educational level, knowledge and beliefs regarding SARS-CoV-2, personal protection measures, beliefs regarding vaccination, vaccination status, reasons for not been vaccinated against SARS-CoV-2, feelings of regret for not been vaccinated, and willingness to be vaccinated in the future. All adult patients with COVID-19 were eligible, regardless of their vaccination status against SARS-CoV-2. Results: In total, 162 patients agreed and participated in the study, with 97% of them suffering severe COVID-19. Their median age was 56 years, and 59.9% (97 patients) were male. Among them, 43.8% had been vaccinated against COVID-19. When unvaccinated patients were asked the reasons for not being vaccinated, the most frequent responses were that they were waiting for more scientific data, due to uncertainty about long-term consequences of the vaccine, and their fear of thrombosis. When at discharge, unvaccinated hospitalized COVID-19 patients were asked whether they would get vaccinated if they could turn time back, and 64.7% of them replied positively. Conclusions: The study reveals several patients’ fears and misconceptions and suggests that there is room for implementing measures that could reduce knowledge gaps allowing for improvement of vaccination rates against COVID-19. Full article
Show Figures

Figure 1

8 pages, 1118 KiB  
Case Report
A Rare Case of Pulmonary and Gastrointestinal Mucormycosis Due to Rhizopus spp. in a Child with Chronic Granulomatous Disease
by Nnennaya U. Opara
Infect. Dis. Rep. 2022, 14(4), 579-586; https://doi.org/10.3390/idr14040062 - 8 Aug 2022
Cited by 3 | Viewed by 2574
Abstract
Mucormycosis is a rare but serious fungal infection caused by a mold family known as the Mucorales. These fungi exist throughout the environment, especially in the soil, leaves, compost piles, or decaying woods. Humans contract mucormycosis by coming in contact with the spores [...] Read more.
Mucormycosis is a rare but serious fungal infection caused by a mold family known as the Mucorales. These fungi exist throughout the environment, especially in the soil, leaves, compost piles, or decaying woods. Humans contract mucormycosis by coming in contact with the spores from fungus either by inhalation or through cuts on the skin. The population at risk for this life-threatening infection includes diabetes mellitus patients, cancer patients, premature infants, burn patients, and immunocompromised patients. The fungi that most commonly cause mucormycosis are the Rhizopus species, and the least represented are Apophysomyces species. Common clinical manifestations of mucormycosis include pulmonary, cutaneous, rhinocerebral, and gastrointestinal mucormycosis. Cases of lung mucormycosis are often misdiagnosed because of non-specific clinical symptoms and radiological features, and in many cases, have been diagnosed as aspergillosis due to similarities in signs, symptoms, and imaging presentation of the lungs. We present a pediatric case of a 6-year-old from Togo who presented to our hospital in Nigeria with dyspnea, fever, and abdominal pain of five-day duration. The child’s symptoms began 6-months prior, with dry cough, fever, fatigue, and chest pain and abdominal pain. The hospital in Togo where he lived suspected infection with tuberculosis (TB) despite a false-positive Mantoux test and negative chest X-ray. He was initially treated for TB with Isoniazid and vitamin B6 and was discharged home. Six months later, his symptoms have not improved, but became more severe with high grade fever 40 °C (oral reading), anorexia, fatigue, tachypnea, abdominal distention, and cough. The patient was immediately referred to our hospital in Abuja, Nigeria where more specific tests were ordered. He was eventually diagnosed with chronic granulomatous disease induced pulmonary and gastrointestinal (GI) mucormycosis due to Rhizopus spp. In this report, we discuss an unusual clinical presentation of an infection caused by Rhizopus spp., its management, and outcomes in a child with chronic granulomatous disease (CGD). Full article
(This article belongs to the Section Fungal Infections)
Show Figures

Figure 1

5 pages, 219 KiB  
Brief Report
Efficacy and Safety of the Treatment of Chronic Hepatitis C with Sofosbuvir/Ledipasvir in Children Aged 5 to 10 Years with Comorbidities—A Brief Report
by Maria Pokorska-Śpiewak, Anna Dobrzeniecka and Agnieszka Ogrodnik
Infect. Dis. Rep. 2022, 14(4), 574-578; https://doi.org/10.3390/idr14040061 - 3 Aug 2022
Cited by 1 | Viewed by 2016
Abstract
The efficacy and safety of 12 weeks of therapy with sofosbuvir/ledipasvir in three patients aged 5–10 years are presented. All three children suffered from comorbidities, including chronic kidney disease in two. All participants achieved a sustained virologic response 12 weeks after the end [...] Read more.
The efficacy and safety of 12 weeks of therapy with sofosbuvir/ledipasvir in three patients aged 5–10 years are presented. All three children suffered from comorbidities, including chronic kidney disease in two. All participants achieved a sustained virologic response 12 weeks after the end of treatment. No adverse effects were reported during or after the treatment, and the compliance was good. Decisions on starting treatment in children below 6 years of age should be made individually, taking compliance into consideration. The adjustment of formulation and dosing of medication during treatment is necessary in young children. Further research with larger groups of patients is needed to confirm our findings. Full article
(This article belongs to the Special Issue Viral Hepatitis: Epidemiological Features and Prevention)
5 pages, 676 KiB  
Brief Report
Molecular Epidemiology of Sporadic and Outbreak-Related Salmonella Typhi Isolates in the Brazilian North Region: A Retrospective Analysis from 1995 to 2013
by Ana Judith Pires Garcia Quaresma, Yan Corrêa Rodrigues, Joseline Barbosa Aboim, Mayza Miranda Bezerra, Maria Isabel Montoril Gouveia, Ana Roberta Fusco Da Costa, Cintya de Oliveira Souza, Flávia Corrêa Bastos, Luana Nepomuceno Gondim Costa Lima, Francisco Lúzio de Paula Ramos and Karla Valéria Batista Lima
Infect. Dis. Rep. 2022, 14(4), 569-573; https://doi.org/10.3390/idr14040060 - 3 Aug 2022
Cited by 3 | Viewed by 2132
Abstract
Typhoidal salmonellosis is a global public health problem occurring in developing endemic regions. In Brazil, cases are mostly registered in the North and Northeast regions. Molecular characterization of the strains is important to understand the epidemiology of disease infections and to design control [...] Read more.
Typhoidal salmonellosis is a global public health problem occurring in developing endemic regions. In Brazil, cases are mostly registered in the North and Northeast regions. Molecular characterization of the strains is important to understand the epidemiology of disease infections and to design control strategies. The present study retrospectively evaluates the genotyping features of sporadic and outbreak-related Salmonella Typhi isolates from the Brazilian North region. Bacterial isolates were recovered from blood and a rectal swab of patients in the states of Acre and Pará, Brazilian North region, in the period of 1995 to 2013, and were submitted to genotyping by applying Multilocus sequence typing (MLST) and Pulsed Field Gel Electrophoresis (PFGE) reference methods. MLST genotyping revealed the presence of epidemic clones ST1 and ST2, and 20 pulsotypes were identified by PFGE, including four distinct clusters (A–D), and six subclusters (A1–D1) with indistinguishable strains in different periods and locations. To conclude, the obtained data demonstrates the temporal stability, adaptation, and transmission of outbreak-related and sporadic S. Typhi strains over time, contributing to the transmission chain in the region. Full article
(This article belongs to the Section Neglected Tropical Diseases)
Show Figures

Figure 1

11 pages, 301 KiB  
Review
Impact of COVID-19 on the Changing Patterns of Respiratory Syncytial Virus Infections
by Ishan Garg, Rahul Shekhar, Abu Baker Sheikh and Suman Pal
Infect. Dis. Rep. 2022, 14(4), 558-568; https://doi.org/10.3390/idr14040059 - 24 Jul 2022
Cited by 41 | Viewed by 6934
Abstract
Seasonal epidemics of respiratory syncytial virus (RSV) is one of the leading causes of hospitalization and mortality among children. Preventive measures implemented to reduce the spread of SARS-CoV-2, including facemasks, stay-at-home orders, closure of schools and local-national borders, and hand hygiene, may have [...] Read more.
Seasonal epidemics of respiratory syncytial virus (RSV) is one of the leading causes of hospitalization and mortality among children. Preventive measures implemented to reduce the spread of SARS-CoV-2, including facemasks, stay-at-home orders, closure of schools and local-national borders, and hand hygiene, may have also prevented the transmission of RSV and influenza. However, with the easing of COVID-19 imposed restrictions, many regions are noticing a delayed RSV outbreak. Some of these regions have also noted an increase in severity of these delayed RSV outbreaks partly due to a lack of protective immunity in the community following a lack of exposure from the previous season. Lessons learned from the COVID-19 pandemic can be implemented for controlling RSV outbreaks, including: (1) measures to reduce the spread, (2) effective vaccine development, and (3) genomic surveillance tools and computational modeling to predict the timing and severity of RSV outbreaks. These measures can help reduce the severity and prepare the health care system to deal with future RSV outbreaks by appropriate and timely allocation of health care resources. Full article
11 pages, 322 KiB  
Article
Factors Associated with Unprotected Anal Sex among Men Who Have Sex with Men in Mexico
by Ramiro Caballero-Hoyos, Joel Monárrez-Espino, María Guadalupe Ramírez-Ortíz and Francisco Martín Cárdenas-Medina
Infect. Dis. Rep. 2022, 14(4), 547-557; https://doi.org/10.3390/idr14040058 - 21 Jul 2022
Cited by 3 | Viewed by 7895
Abstract
The global prevalence of HIV is notably higher in men who have sex with men (MSM) compared with other male populations. Unprotected anal intercourse is the riskiest sexual behavior for HIV acquisition and/or transmission among this minority population. The purpose of the study [...] Read more.
The global prevalence of HIV is notably higher in men who have sex with men (MSM) compared with other male populations. Unprotected anal intercourse is the riskiest sexual behavior for HIV acquisition and/or transmission among this minority population. The purpose of the study was to identify if the syndemic of psychosocial stressors and experienced stigma are predictors of unprotected anal sex in Mexican MSM. A cross-sectional analytic study was carried out. It included adults residing in Manzanillo, Mexico, with oral/anal sex practices within the last year. Informed consent was given by 142 participants selected using snowball sampling. Collected data included sociodemographic characteristics, psychosocial stressors, experienced stigma, HIV knowledge, knowing a friend/acquaintance living with HIV/AIDS, and sexual risk behaviors. Adjusted logistic regression was used to identify predictors of unprotected anal sex within the last six months. Presence of syndemic of psychosocial stressors, drug use during sex, having friends/acquaintances with HIV/AIDS, and experiencing high stigma were positively associated; high level of HIV knowledge was negatively linked. Reducing psychosocial stressors and integrating stigma-mitigation strategies are key elements to reduce HIV transmission. Full article
(This article belongs to the Special Issue HIV/AIDS: Transmission, Prevention and Treatment)
10 pages, 288 KiB  
Review
Mix-and-Match COVID-19 Vaccinations (Heterologous Boost): A Review
by Ishan Garg, Abu Baker Sheikh, Suman Pal and Rahul Shekhar
Infect. Dis. Rep. 2022, 14(4), 537-546; https://doi.org/10.3390/idr14040057 - 20 Jul 2022
Cited by 26 | Viewed by 3825
Abstract
Various safe and effective COVID-19 vaccines utilizing different platforms (mRNA, adenovirus vector, inactivated virus-based) are available against SARS-CoV-2 infection. A prime-boost regimen (administration of two doses) is recommended to induce an adequate and sustained immune response. Most of these vaccines follow a homologous [...] Read more.
Various safe and effective COVID-19 vaccines utilizing different platforms (mRNA, adenovirus vector, inactivated virus-based) are available against SARS-CoV-2 infection. A prime-boost regimen (administration of two doses) is recommended to induce an adequate and sustained immune response. Most of these vaccines follow a homologous regimen (the same type of vaccine as priming and booster doses). However, there is a growing interest in a heterologous prime-boost vaccination regimen to potentially help address concerns posed by fluctuating vaccine supplies, serious adverse effects (anaphylaxis and thromboembolic episodes following adenovirus-based vaccines), new emerging virulent strains, inadequate immune response in immunocompromised individuals, and waning immunity. Various studies have demonstrated that heterologous prime-boost vaccination may induce comparable or higher antibody (spike protein) titers and a similar reactogenicity profile to the homologous prime-boost regimen. Based on these considerations, the Center for Disease Control and Prevention has issued guidance supporting the “mix-and-match” heterologous boost COVID-19 vaccine strategy. Full article
12 pages, 944 KiB  
Article
Risk Factors Associated with Avian Influenza Subtype H9 Outbreaks in Poultry Farms of Central Lowland Nepal
by Deepak Subedi, Parshuram Phuyal, Suman Bhandari, Milan Kandel, Shambhu Shah, Gaurav Rawal, Surendra Karki and Santosh Dhakal
Infect. Dis. Rep. 2022, 14(4), 525-536; https://doi.org/10.3390/idr14040056 - 18 Jul 2022
Cited by 5 | Viewed by 3818
Abstract
Low pathogenic avian influenza (LPAI) of subtype H9 outbreaks have been frequently occurring in major commercial hubs of Nepal including Chitwan, a central lowland area, causing substantial economic losses to the farmers. However, the risk factors associated with these outbreaks have been poorly [...] Read more.
Low pathogenic avian influenza (LPAI) of subtype H9 outbreaks have been frequently occurring in major commercial hubs of Nepal including Chitwan, a central lowland area, causing substantial economic losses to the farmers. However, the risk factors associated with these outbreaks have been poorly understood, and hence, this case-control study was conducted in Chitwan, Nawalpur, and Makawanpur districts of Nepal from October 2019 to March 2020. A total of 102 farms were selected in which 51 were case farms, and 51 were controls. Case farms were avian influenza (AI)-subtype-H9-confirmed farms through polymerase chain reaction (PCR) assays on poultry samples. Control farms included farms that were AI-negative in the antigen test brought to the National Avian Disease Investigation Laboratory, Chitwan, for diagnosis during the study period. Each farm was visited to collect information using a semi-structured questionnaire. A total of 25 variables representing farm characteristics and biosecurity measures were considered as potential risk factors. The final multivariable model showed that distance of less than 0.5 km from the main road (OR = 4.04, 95% CI = 1.20–13.56, p = 0.023), distance of less than 1 km from a nearest infected farm (OR = 76.42, 95% CI = 7.17–814.06, p = 0.0003), and wild birds coming around the farm (OR = 6.12, 95% CI = 1.99–18.79, p = 0.0015) were risk factors for avian influenza type H9, whereas using apron or separate cloth inside the shed (OR = 0.109, 95% CI = 0.020–0.577, p = 0.0092) was shown to reduce the risk of farms being positive for AI subtype H9. These findings suggest that due consideration should be given to site selection while establishing the farms and the importance of implementing appropriate biosecurity measures, such as using separate cloth inside the shed and preventing the entry of wild birds inside the farm to reduce the potential risk of introduction of avian influenza type H9 to their poultry farms. Full article
(This article belongs to the Section Viral Infections)
Show Figures

Figure 1

16 pages, 863 KiB  
Review
Health-Related Quality of Life (HRQoL) of Patients with Tuberculosis: A Review
by Sandul Yasobant, Mahalaqua Nazli Khatib, Zahiruddin Quazi Syed, Abhay M. Gaidhane, Harsh Shah, Kiran Narkhede, Priya Bhavsar, Jay Patel, Anish Sinha, Tapasvi Puwar, Somen Saha and Deepak Saxena
Infect. Dis. Rep. 2022, 14(4), 509-524; https://doi.org/10.3390/idr14040055 - 18 Jul 2022
Cited by 12 | Viewed by 4530
Abstract
Tuberculosis (TB) is a major killer and cause of human suffering worldwide and imposes a substantial reduction in patients’ health-related quality of life (HRQoL). HRQoL indicates the consciousness of patients regarding their physical and mental health. It is, therefore, very relevant in comprehending [...] Read more.
Tuberculosis (TB) is a major killer and cause of human suffering worldwide and imposes a substantial reduction in patients’ health-related quality of life (HRQoL). HRQoL indicates the consciousness of patients regarding their physical and mental health. It is, therefore, very relevant in comprehending and measuring the exact impact of the disease state. Therefore, we undertook this review to summarize the available evidence on the impact of TB and its treatment on HRQoL. An in-depth understanding of HRQoL in TB patients can identify the existing management gaps. We undertook a systematic search through PubMed and CENTRAL. Data were extracted and tabulated for study design, targeted population, QoL instrument used, QoL domain assessed, and key findings. We included studies that assessed the effect of TB on the QoL both during and after treatment. There are no specific HRQoL assessment tools for utilization among TB patients. HRQoL is markedly impaired in patients with TB. The factors affecting HRQoL differ with active and latent TB, socio-demographics, socio-economic status, presence of co-infections, etc. This review’s findings can help to frame appropriate policies for tackling HRQoL issues in TB patients. Full article
(This article belongs to the Section Tuberculosis and Mycobacteriosis)
Show Figures

Figure 1

4 pages, 404 KiB  
Case Report
Neurocysticercosis in Low- and Middle-Income Countries, a Diagnostic Challenge from Oyam District, Uganda
by Francesco Vladimiro Segala, Elda De Vita, James Amone, Daniel Ongaro, Ritah Nassali, Bonny Oceng, Samuel Okori, Giovanni Putoto, Peter Lochoro, Jerry Ictho, Massimo Fantoni, Annalisa Saracino and Francesco Di Gennaro
Infect. Dis. Rep. 2022, 14(4), 505-508; https://doi.org/10.3390/idr14040054 - 1 Jul 2022
Cited by 3 | Viewed by 2135
Abstract
Background: In countries where Taenia solium is endemic, neurocysticercosis (NCC) is the leading identified cause of seizures, accounting for nearly 30% of all epilepsy cases and up to 2.8 million of Disability Adjusted Life Years. Diagnosis of this condition, however, is strictly reliant [...] Read more.
Background: In countries where Taenia solium is endemic, neurocysticercosis (NCC) is the leading identified cause of seizures, accounting for nearly 30% of all epilepsy cases and up to 2.8 million of Disability Adjusted Life Years. Diagnosis of this condition, however, is strictly reliant on either MRI or CT scan, which are poorly available in low- and middle-income countries (LMICs), creating challenges for proper case management and the acquisition of precise neuroepidemiologic data that may guide program and policy development. Methods: Here, we report the case of a 73-year-old woman admitted in a rural hospital in Northern Uganda, who presented with seizures and a progressive inability to walk. She was then diagnosed with NCC after a brain CT scan. Conclusions: This case study represents a rare example of the detection of NCC in a rural district hospital, thus suggesting the potential feasibility of a CT-scan guided diagnostic approach in low resource settings. Full article
Show Figures

Figure 1

4 pages, 705 KiB  
Communication
Emergence of the G118R Pan-Integrase Resistance Mutation as a Result of Low Compliance to a Dolutegravir-Based cART
by Helene Mens, Lasse Fjordside, Jannik Fonager and Jan Gerstoft
Infect. Dis. Rep. 2022, 14(4), 501-504; https://doi.org/10.3390/idr14040053 - 22 Jun 2022
Cited by 3 | Viewed by 2151
Abstract
HIV-1 resistance towards integrase inhibitors is a potential threat of the success of HIV-1 combination treatment. G118R is a rare drug resistance mutation conferring pan-integrase resistance. Here, we describe the occurrence of G118R in a HIV-1 subtype-B-positive individual with major compliance problems, detected [...] Read more.
HIV-1 resistance towards integrase inhibitors is a potential threat of the success of HIV-1 combination treatment. G118R is a rare drug resistance mutation conferring pan-integrase resistance. Here, we describe the occurrence of G118R in a HIV-1 subtype-B-positive individual with major compliance problems, detected while the patient was on dolutegravir-based cART. We speculate the pre-selection of M184I/V aided the occurrence of G118R in this case, and discuss the robustness of dolutegravir-based therapies. Full article
(This article belongs to the Special Issue HIV/AIDS: Transmission, Prevention and Treatment)
Show Figures

Figure 1

Previous Issue
Next Issue
Back to TopTop